J Frontier Co., Ltd. (2934) AI Stock Analysis

• Market Cap: ¥6.69B
• Dividend Yield: N/A
• Average Volume (3M): 40.58K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.03
• Revenue Growth: 11.40%
• EPS Growth: N/A
• Country: JP
• Employees: 315
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -29.46
• Shares Outstanding: 5,333,465
• 10 Day Avg. Volume: 58,880
• 30 Day Avg. Volume: 40,583
• PEG Ratio: -0.89
• Price to Book (P/B): 5.74
• Price to Sales (P/S): 0.38
• P/FCF Ratio: 18.06
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: ¥1,205.00 ▼(-9.13% Downside)
• Action: Reiterated Date: 12/03/25
• Date: Action: Reiterated 12/03/25

The overall stock score is primarily impacted by the company's financial performance challenges and bearish technical indicators. The high P/E ratio suggests overvaluation, further contributing to a low score. The lack of earnings call data and corporate events means these factors did not influence the score.

Positive Factors

Healthcare market exposure

Operating in the healthcare and wellness sector exposes the company to structurally durable demand for health-related products and services. This industry positioning supports a steadier customer base and recurring needs, helping stabilize revenue sources over the medium term.

Free cash flow improvement

Reported improvement in free cash flow growth and a favorable free-cash-flow-to-net-income ratio suggest growing ability to convert earnings into cash. Sustained FCF enhances capacity to service debt, fund reinvestment, and provide financial flexibility even if operating cash flow remains uneven.

Recent EPS improvement

A near-95% EPS growth reading alongside reported net margin improvements points to meaningful gains in profitability. If sustained, this indicates improving operational efficiency or favorable mix effects that can underpin longer-term earnings power and cash generation.

Negative Factors

High leverage

A high debt-to-equity posture raises financing risk and constrains strategic flexibility. Elevated leverage increases interest obligations and vulnerability to rate or demand shocks, making it harder to sustain investments or weather revenue volatility without deleveraging measures.

Inconsistent operating cash flow

Inconsistent operating cash flow and a negative OCF-to-net-income ratio signal that reported profits don’t reliably convert to cash. That undermines the predictability of internal funding for capex, working capital, and debt service, increasing dependence on external financing.

Volatile revenue and margins

Inconsistent revenue growth and materially fluctuating net margins point to execution or demand variability. Such volatility impairs planning, weakens operating leverage benefits, and raises the bar for management to stabilize top-line trends and restore consistent profitability.

J Frontier Co., Ltd. Business Overview & Revenue Model

Company Description

J Frontier Co.,Ltd. engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. It is involved in various activities, including online medical care, medication guidance, as well as operates drug delivery platform, medical institutions, and operates dispensing pharmacy. The company engages in distribution of pharmaceuticals products as well as involved in marketing, logistics, and call center activities. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Tokyo, Japan.

How the Company Makes Money

null

J Frontier Co., Ltd. Financial Statement Overview

Summary

J Frontier Co., Ltd. faces challenges in maintaining consistent revenue growth and profitability, with high leverage posing potential risks. While there are signs of improvement in cash flow, the company needs to focus on stabilizing its financial performance and managing debt levels to enhance long-term sustainability.

Income Statement

The income statement shows a mixed performance. Gross profit margin has been relatively stable, but the net profit margin has fluctuated significantly, with recent improvements. Revenue growth has been inconsistent, with a notable decline in the latest period. EBIT and EBITDA margins have also been volatile, indicating challenges in maintaining operational efficiency.

Balance Sheet

The balance sheet indicates a high debt-to-equity ratio, suggesting potential leverage risks. However, the equity ratio has been relatively stable. Return on equity has been negative in recent periods, reflecting profitability challenges. The company needs to manage its debt levels to improve financial stability.

Cash Flow

Cash flow analysis shows improvement in free cash flow growth, but operating cash flow has been inconsistent. The operating cash flow to net income ratio has been negative, indicating cash flow challenges. However, the free cash flow to net income ratio suggests some ability to generate cash relative to net income.

Breakdown	May 2024	May 2023	May 2022	May 2022	May 2021
Income Statement
Total Revenue	21.50B	17.71B	16.84B	11.88B	8.49B
Gross Profit	9.57B	8.33B	7.12B	5.40B	6.63B
EBITDA	914.54M	-1.22B	-1.54B	760.66M	706.10M
Net Income	87.57M	-2.09B	-1.90B	400.52M	424.93M
Balance Sheet
Total Assets	9.17B	11.41B	7.25B	6.10B	2.59B
Cash, Cash Equivalents and Short-Term Investments	2.17B	1.81B	1.65B	2.96B	1.64B
Total Debt	4.34B	5.16B	2.14B	544.39M	75.21M
Total Liabilities	7.16B	9.53B	4.54B	1.94B	1.33B
Stockholders Equity	1.41B	1.14B	2.48B	4.14B	1.27B
Cash Flow
Free Cash Flow	447.19M	-1.54B	-1.94B	-377.40M	823.99M
Operating Cash Flow	509.01M	-1.44B	-1.83B	-366.94M	830.91M
Investing Cash Flow	470.79M	-1.79B	-1.13B	-860.09M	-7.99M
Financing Cash Flow	-623.13M	3.39B	1.45B	2.56B	-93.65M

J Frontier Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1326.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2934, the sentiment is Negative. The current price of 1326 is above the 20-day moving average (MA) of 1263.25, below the 50-day MA of 1336.94, and below the 200-day MA of 1594.65, indicating a bearish trend. The MACD of -24.19 indicates Negative momentum. The RSI at 44.04 is Neutral, neither overbought nor oversold. The STOCH value of 60.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2934.

J Frontier Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3902	63 Neutral	¥65.59B	228.03	―	0.39%	6.17%	-8918.66%
4483	63 Neutral	¥214.31B	26.76	―	0.43%	20.55%	48.62%
9218	52 Neutral	¥7.56B	33.39	―	―	41.16%	2750.91%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
4480	51 Neutral	¥57.19B	77.03	5.76%	―	31.95%	-40.95%
4438	50 Neutral	¥2.91B	-4.28	―	―	16.19%	-4.42%
2934	42 Neutral	¥6.69B	-12.58	―	―	11.40%	―